S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TVTX Travere Therapeutics Inc

21.25

-0.73 (-3.32%)

25 Feb 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics Inc News

Travere Therapeutics to Participate at Upcoming Investor Conferences
Tuesday 25 February 2025 (8 hours ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 21 February 2025 (4 days ago) • Edgar (US Regulatory)

Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Friday 21 February 2025 (4 days ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (1 week ago) • Edgar (US Regulatory)

Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Friday 14 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 13 February 2025 (2 weeks ago) • GlobeNewswire Inc.

More Travere Therapeutics Inc News Articles

Australian SE All Ordina...

Westpac Banking

National Australia Bank

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions